Skip to main content
SpringerLink
Log in

Antipsychotics: first-line treatments for behavioural and psychological symptoms of dementia

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stoppe G, Brandt CA, Staedt JH. Behavioural problems associated with dementia. The role of newer antipsychotics. Drugs Aging 1999 Jan; 14(1): 41–54

    Article  PubMed  CAS  Google Scholar 

  2. Hemels MEH, Lanctôt KL, Iskedjian M, et al. Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia. Drugs Aging 2001; 18(7): 527–50

    Article  PubMed  CAS  Google Scholar 

  3. Alexopoulos G, Silver J, Kahn D, et al., editors. Treatment of agitation in older persons with dementia. Postgrad Med (Special issue), 1998

  4. Board of Directors of the American Association for Geriatric Psychiatry, Clinical Practice Committee of the American Geriatrics Society, and committee on long-term care and treatment of the elderly. Psychotherapeutic medications in the nursing home. J Am Geriatr Soc 1992; 40: 946–9

    Google Scholar 

  5. Small G, Rabins P, Barry P, et al. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA 1997; 278: 1363–71

    Article  PubMed  CAS  Google Scholar 

  6. De Deyn P, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behaviour symptoms of dementia. Neurology 1999; 53: 946–55

    Article  PubMed  Google Scholar 

  7. Katz IR, Jeste DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999; 60: 107–15

    Article  PubMed  CAS  Google Scholar 

  8. British National Formulary No. 42, London: The Pharmaceutical Press, 2001 Sep

  9. Porsteinsson AP, Tariot PN, Erb R, et al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry 2001 Winter; 9(1): 58–66

    PubMed  CAS  Google Scholar 

  10. Grossman F. A review of anticonvulsants in treating agitated demented elderly patients. Pharmacotherapy 1998; 18: 600–6

    PubMed  CAS  Google Scholar 

  11. Street J, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer’s disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HEGU Study Group. Arch Gen Psychiatry 2000; 57: 968–76

    Article  PubMed  CAS  Google Scholar 

  12. Tariot PN, Erb R, Podgorski C, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155: 54–61

    PubMed  CAS  Google Scholar 

  13. Class C, Schneider L, Farlow M. Optimal management of behavioural disorders associated with dementia. Drugs Aging 1997; 10: 95–106

    Article  PubMed  CAS  Google Scholar 

  14. Pozuelo L, Franco K, Palmer R. Agitated dementia: drug vs nondrug treatment. Cleveland Clin J Med 1998; 65: 191–9

    CAS  Google Scholar 

  15. Tariot PN, Cohen RM, Sunderland T. L-deprenyl in Alzheimer disease: preliminary evidence for behavioral change with monoamine oxidase B inhibition. Arch Gen Psychiatry 1987; 44: 427–33

    Article  PubMed  CAS  Google Scholar 

  16. Lanctôt KL, Herrmann N, Liu BA, Economic appraisal of pharmacologic therapy for behavioral disorders in dementia [abstract PII-34]. Clin Pharmacol Ther 1999; 61: 173

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antipsychotics: first-line treatments for behavioural and psychological symptoms of dementia. Drugs Ther. Perspect 18, 15–18 (2002). https://doi.org/10.2165/00042310-200218030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218030-00006

Keywords

Search

Navigation